Tb Drug Multi-drug Resistant
- All
- News
-
1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert Zarir Udwadia
New Delhi: About 8,000 patients pass through Dr Zarir F Udwadia’s busy clinic every year. The patients who are usually referred to him by colleagues from different parts of the country are difficult cases of multi-drug resistant tuberculosis (MDR-TB). An expert in drug-resistant tuberculosis and interstitial lung disease (ILD), Dr Udwadia is curr...
-
Drug Resistant TB - What Should You Know
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...
-
XDR and MRD: The Rise of Drug Resistant Tuberculosis
The rise of multi-drug resistant (MDR) and extensively drug resistant tuberculosis is threatening to outdo years of progress in controlling the disease.
-
Drug Resistant TB - What Should You Know
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...
-
Drug Resistant TB Rose From Under 5% In 2000 To Nearly 20% In 2012: Study
A study based on a retrospective analysis of patient data at Sir Ganga Ram Hospital in New Delhi has revealed a 12 per cent increase in the incidence of multi-drug resistant tuberculosis (MDR-TB) in India between 2000 and 2012. Nearly 15,000 patients were subject to mycobacterial culture during the study.
-
US health authorities approve new TB drug, first in 40 years
US health authorities have approved a new medicine to fight multi-drug resistant TB, the first to be approved in the country in more than four decades.
_636269922989425542.jpg?downsize=260:195 "Drug Resistant TB - What Should You Know")
-
1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert Zarir Udwadia
New Delhi: About 8,000 patients pass through Dr Zarir F Udwadia’s busy clinic every year. The patients who are usually referred to him by colleagues from different parts of the country are difficult cases of multi-drug resistant tuberculosis (MDR-TB). An expert in drug-resistant tuberculosis and interstitial lung disease (ILD), Dr Udwadia is curr...
-
Drug Resistant TB - What Should You Know
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...
-
XDR and MRD: The Rise of Drug Resistant Tuberculosis
The rise of multi-drug resistant (MDR) and extensively drug resistant tuberculosis is threatening to outdo years of progress in controlling the disease.
-
Drug Resistant TB - What Should You Know
Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...
-
Drug Resistant TB Rose From Under 5% In 2000 To Nearly 20% In 2012: Study
A study based on a retrospective analysis of patient data at Sir Ganga Ram Hospital in New Delhi has revealed a 12 per cent increase in the incidence of multi-drug resistant tuberculosis (MDR-TB) in India between 2000 and 2012. Nearly 15,000 patients were subject to mycobacterial culture during the study.
-
US health authorities approve new TB drug, first in 40 years
US health authorities have approved a new medicine to fight multi-drug resistant TB, the first to be approved in the country in more than four decades.
